134
Participants
Start Date
May 5, 2022
Primary Completion Date
November 1, 2031
Study Completion Date
December 1, 2031
Trametinib
Mekinist© (Trametinib) taken orally each day with a 18-course schedule of 4 weeks each.
Vinblastine
weekly intra-venous Vinblastine (Velbe©) during 18 courses of 4 weeks each
RECRUITING
APHM, Marseille
NOT_YET_RECRUITING
Chu Dijon Bourgogne, Dijon
RECRUITING
Chu de Besancon, Besançon
RECRUITING
Chu de Brest Morvan, Brest
NOT_YET_RECRUITING
Groupe Hospitalier Pellegrin, Bordeaux
NOT_YET_RECRUITING
Chu de Rennes, Rennes
RECRUITING
Chu Tours, Tours
RECRUITING
Chu Grenoble Alpes, Grenoble
NOT_YET_RECRUITING
Chu Saint Etienne, Saint-Etienne
RECRUITING
Chu D'Angers, Angers
NOT_YET_RECRUITING
CHU de REIMS, Reims
RECRUITING
Chu de Nancy, Vandœuvre-lès-Nancy
RECRUITING
Clcc Oscar Lambret Lille, Lille
RECRUITING
CHU Strasbourg - France, Strasbourg
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Institut Curie, Paris
NOT_YET_RECRUITING
Chu Rouen, Rouen
NOT_YET_RECRUITING
Chu Amiens Picardie, Amiens
NOT_YET_RECRUITING
Chu Poitiers Chu La Miletrie, Poitiers
NOT_YET_RECRUITING
Chu Limoges, Limoges
RECRUITING
Institut Gustave Roussy, Villejuif
NOT_YET_RECRUITING
CHU CAEN, Caen
RECRUITING
Chu Montpellier, Montpellier
NOT_YET_RECRUITING
Chu de Nice, Nice
NOT_YET_RECRUITING
Chu Toulouse, Toulouse
University Hospital, Strasbourg, France
OTHER